Cynda issued a profit warning, expecting a year-on-year increase of 2807.87% to 3211.74% in net profit attributable to the parent company for the first three quarters
I'm PortAI, I can summarize articles.
Cynda expects that the net profit attributable to the parent company in the first three quarters of 2025 will increase by 2807.87% to 3211.74% year-on-year, reaching between 180 million and 205 million yuan. The main reasons include the rise in market prices of its flagship product, oxazolone, and the sales growth of the new product series, pyrazole quinozole. In addition, the company has improved operational efficiency and gross profit margin through operational reforms and gross profit distribution plans
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments